New device advancements build on the global success of L300® and help improve mobility of stroke survivors and individuals with upper motor neuron pathologies VALENCIA, Calif., April 25, 2017 ...
DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”), ...
After the COVID-19 pandemic severely impacted much of its business, Bioventus is on something of a growth spurt this year. Just over a month after going public, the orthopedic therapy developer has ...
CLAY COUNTY, Fla. — New technology is helping local kids put their best foot forward. A breakthrough treatment is having a great impact on local families. Ethan Touchton is like any other sixth-grade ...
Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...
VALENCIA, Calif., Feb. 20, 2018 /PRNewswire/ -- Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced it will feature its full suite of ...
VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the StimRouter®, an implantable neuromodulation device designed to treat chronic ...
VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc., a leading neuromodulation company, announced today two agreements to distribute new devices for patients experiencing neurological impairment. Through ...
VALENCIA, Calif., March 12, 2020 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported neuromodulation devices for the treatment of chronic pain of peripheral nerve ...
For more than a decade, Diana Roberts lived with the effects of multiple sclerosis, particularly the dropped-foot syndrome. “It started when I couldn’t feel my feet,” she said. “And the numbness ...
Bioventus Inc. has acquired medical devices provider Bioness Inc. for a total consideration of $110 million. This includes an up-front payment of $45 million and milestone payments of up to $65 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results